Title	Publication Date	Language	Citations
The World Health Organization Classification of Neoplasms of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting – Airlie House, Virginia, November, 1997	2000/01/01		195
The 5TMM series: a useful in vivo mouse model of human multiple myeloma	2000/01/01		92
Patterns of mortality in sickle cell disease in adults in France and England	2002/01/01		74
Are myeloma patients with renal failure candidates for autologous stem cell transplantation?	2000/01/01		74
Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma	2000/01/01		70
Thalidomide in patients with advanced multiple myeloma: a study of 83 patients–report of the intergroupe francophone du myélome (IFM)	2002/01/01		60
Amplification of a novel c-Kit activating mutation Asn822-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia	2002/01/01		55
Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis?	2000/01/01		54
Tcf/Lef transcription factors during T-cell development: unique and overlapping functions	2000/01/01		50
Surveillance of Aspergillus galactomannan antigenemia for invasive aspergillosis by enzyme-linked immunosorbent assay in neutropenic patients treated for hematological malignancies	2000/01/01		43
The combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is feasible and can be an option for relapsed/refractory multiple myeloma	2002/01/01		39
Recombinant erythropoietin therapy as an alternative to blood transfusions in infants with hereditary spherocytosis	2000/01/01		39
Chronic myeloid leukemia cells resistant to interferon-α lack STAT1 expression	2000/01/01		38
Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales	2002/01/01		36
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells	2002/01/01		36
A comparison in normal individuals and sickle cell patients of reduced glutathione precursors and their transport between plasma and red cells	2000/01/01		35
Pregnancy-associated risk for venous thromboembolism and pregnancy outcome in women homozygous for factor V Leiden	2000/01/01		35
The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients	2000/01/01		33
Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features	2002/01/01		33
Cladribine combined with cyclophosphamide is highly effective in the treatment of chronic lymphocytic leukemia	2002/01/01		32
Cyclin D1 expression in patients with multiple myeloma	2000/01/01		32
Classical and new prognostic factors in chronic lymphocytic leukemia: Where to now?	2002/01/01		27
All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial	2002/01/01		27
Thalidomide in patients with advanced multiple myeloma	2000/01/01		26
Specific dose-response effects of TGF-β1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood	2000/01/01		25
Autologous peripheral blood progenitor cell transplantation with <2×106 CD34+/kg: an analysis of variables concerning mobilisation and engraftment	2000/01/01		25
Stem cell defect in aplastic anemia: reduced long term culture-initiating cells (LTC-IC) in CD34+ cells isolated from aplastic anemia patient bone marrow	2002/01/01		25
Cytokine release by activated T-cells in large granular lymphocytic leukemia associated with autoimmune disorders	2002/01/01		24
Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations	2002/01/01		23
Phenotypic and functional analysis of the HLA-class I-specific inhibitory receptors of natural killer cells isolated from peripheral blood of patients undergoing bone marrow transplantation from matched unrelated donors	2000/01/01		22